Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
RhoVac APS
With
Dantrials Aps
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Patients prostatectomised (PT) due to histologically verified adenocarcinoma of the prostate gland who currently are not being treated, or expected within the next 8 months to be treated, with any anti-cancer treatment.
ECOG performance status 0 or 1.
You may not be if
Patient has been treated with Androgen Deprivation Therapy (ADT), or expected to receive such treatment within the next 8 months from enrolment.
Severe medical conditions, such as but not limited to severe asthma/chronic obstructive pulmonary disease (COPD), New York Heart Association (NYHA) grading 3 or above, poorly regulated insulin dependent diabetes, any significant organ damage as judged by the Investigator.
Clareo Health | RV001V, a RhoC Anticancer Vaccine, Against Metastasis From Solid Tumours
